Histogen Inc. (HSTO) |
|
1.5 0.05 (3.45%)
|
09-29 00:51 |
|
Open: |
1.42 |
Pre. Close: |
1.45 |
|
High:
|
1.58 |
Low:
|
1.42 |
|
Volume:
|
38,734 |
Market Cap:
|
18M |
|
|
|
|
Histogen Inc., formerly Conatus Pharmaceuticals Inc., is a regenerative medicine company. The Company is focused on developing technologies that replace and regenerates tissues in the body. The company’s technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address unmet medical needs. The Company has product candidates in clinical development intended to address and offer treatment for hair loss, dermal filler and treatment for joint cartilage repair. The Company manufactures a soluble multipotent cell conditioned media (CCM), which is the starting material for products for hair growth, skin care and other applications. In addition to this, the Company also manufactures an insoluble extracellular matrix (ECM) for applications such as orthopedics, wound care and soft tissue augmentation. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.581 - 1.589 |
1.589 - 1.596 |
|
Low:
|
1.403 - 1.411 |
1.411 - 1.418 |
|
Close:
|
1.487 - 1.5 |
1.5 - 1.512 |
|
Technical analysis |
as of: 2020-09-28 4:33:39 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 2.12  One year: 2.50 |
| Support: |
Support1: 1.30 Support2: 1.08 |
| Resistance: |
Resistance1: 1.82 Resistance2: 2.14 |
| Pivot: |
1.61 |
| Moving Average: |
MA(5): 1.49 MA(20): 1.67
MA(100): 2.64 MA(250): |
| MACD: |
MACD(12,26): -0.22 Signal(9): -0.23 |
| Stochastic oscillator: |
%K(14,3): 21.14 %D(3): 13.69 |
| RSI: |
RSI(14): 29.00 |
| 52-week: |
High: 5.26 Low: 0.23 Change(%): 328.6 |
| Average Vol(K): |
3-Month: 11590 10-Days: 37616 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.HSTO has closed above bottom band by 22.4%. Bollinger Bands are 75.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to HSTO's normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Thu, 17 Sep 2020
Histogen Inc. (NASDAQ:HSTO) Stock is Soaring, Here is Why - The Oracle Dispatch
Thu, 17 Sep 2020
Histogen Inc. (HSTO) is on the roll with an average volume of 55.93K in the recent 3 months - The InvestChronicle
Thu, 17 Sep 2020
Histogen Inc. (HSTO) volume hits 2.95 million: A New Opening for Investors - News Daemon
Wed, 16 Sep 2020
Histogen Announces $2M Grant Award from the Department of Defense for Clinical Advancement of HST-003 for Cartilage Regeneration in the Knee - GlobeNewswire
Wed, 16 Sep 2020
Histogen Inc. (NASDAQ:HSTO) stock sentiment check: What does Wall Street Say? - Stocks Register
Wed, 16 Sep 2020
Histogen Inc. (HSTO) Announces $2M Grant Award from the Department of Defense for Clinical Advancement of HST-003 for Cartilage Regeneration in the Knee - StreetInsider.com
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
12 |
| Shares Float (M) |
8 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
30 |
|
Shares Short P. Month (K)
|
55 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-384.47 |
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
-92.4 |
|
Gross Profit (p.s.)
|
0.251 |
|
Sales Per Share
|
0.242 |
|
EBITDA (p.s.)
|
-0.922 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-8 |
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
6.19 |
|
Price to Cash Flow
|
-2.19 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
